Squarepoint Ops LLC Arcturus Therapeutics Holdings Inc. Transaction History

Squarepoint Ops LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$8.91 - $14.41 $312,634 - $505,618	35,088 New	35,088 $456,000
Q4 2024 Feb 14, 2025	SELL	$14.82 - $25.48 $337,184 - $579,720	-22,752 Reduced 69.25%	10,102 $171,000
Q3 2024 Nov 14, 2024	BUY	$18.08 - $25.38 $60,658 - $85,149	3,355 Added 11.37%	32,854 $762,000
Q2 2024 Aug 14, 2024	BUY	$24.35 - $44.39 $718,300 - $1.31 Million	29,499 New	29,499 $718,000
Q4 2023 Feb 14, 2024	BUY	$17.71 - $32.97 $155,759 - $289,971	8,795 New	8,795 $277,000

Q2 2021 Aug 16, 2021	SELL	$25.79 - $42.11 $222,026 - $362,524	-8,609 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$38.75 - $86.92 $333,598 - $748,294	8,609 New	8,609 $356,000
Q3 2020 Nov 16, 2020	SELL	$37.49 - $63.19 $179,802 - $303,059	-4,796 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $60,717 - $279,462	4,796 New	4,796 $224,000
Q1 2020 May 15, 2020	SELL	$9.31 - $18.26 $508,326 - $996,996	-54,600 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$8.93 - $12.41 $148,238 - $206,006	16,600 Added 43.68%	54,600 $594,000
Q3 2019 Nov 14, 2019	BUY	$8.8 - $14.5 $334,400 - $551,000	38,000 New	38,000 $390,000

173

26M

2.32M

866K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $193M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.